Automedicação no contexto de COVID-19, os perigos da prática e fatores associados

Autores

DOI:

https://doi.org/10.33448/rsd-v12i6.42039

Palavras-chave:

Automedicação; COVID-19; Efeitos colaterais e reações adversas relacionados a medicamentos.

Resumo

Introdução: Com o avanço da pandemia da COVID-19, muitas pessoas buscaram alternativas de tratamento ou prevenção para a doença e aderiram à automedicação, sem levar em conta os possíveis riscos dessa prática. Objetivo: Caracterizar a prática da automedicação no contexto da pandemia de COVID-19, seus perigos e fatores associados. Metodologia: Foi realizada uma revisão integrativa da literatura, com pesquisas nas bases de dados da Biblioteca Virtual em Saúde (BVS), utilizando os seguintes Descritores em Ciências da Saúde (DeCS): “COVID-19” e “automedicação” e o operador booleano “AND”, buscando artigos completos publicados gratuitamente nos últimos cinco anos em inglês, português ou espanhol. Foram encontrados 57 artigos, dos quais 10 foram selecionados para leitura na íntegra a fim de responder a seguinte questão norteadora: “Quais os perigos, os fatores associados e as características da automedicação durante a pandemia de COVID-19?”. Resultados: A automedicação foi praticada por, em média, um terço da população durante a pandemia. Profissionais da saúde, estudantes de medicina e mulheres se automedicaram mais em comparação com o restante da população. As medicações mais utilizadas foram antibióticos, ivermectina, antimaláricos, AINEs e paracetamol, além de suplementos alimentares como zinco, vitamina C e complexos polivitamínicos. Os integrantes dos estudos tiveram fácil acesso a essas medicações. Terapias tradicionais também foram relatadas. Conclusão: A automedicação foi bastante presente, com características heterogêneas de distribuição populacional. A maioria das medicações foi utilizada sem indicação, e algumas podem apresentar riscos consideráveis à saúde. Mais estudos precisam ser realizados acerca do tema.

Referências

Abd‐Elsalam, S., Noor, R. A., Badawi, R., Khalaf, M., Esmail, E. S., Soliman, S., Abd El Ghafar, M. S., Elbahnasawy, M., Moustafa, E. F., Hassany, S. M., Medhat, M. A., Ramadan, H. K., Eldeen, M. A. S., Alboraie, M., Cordie, A., & Esmat, G. (2021). Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study. Journal of Medical Virology, 93(10), 5833–5838. https://doi.org/10.1002/jmv.27122

Alexander, J., Tinkov, A., Strand, T. A., Alehagen, U., Skalny, A., & Aaseth, J. (2020). Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19. Nutrients, 12(8), 2358. https://doi.org/10.3390/nu12082358

AlShoaibi, N. A., Maghrabi, K., Alanazi, H., Harbi, M. Al, & Alghamdi, S. (2020). Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19. Annals of Saudi Medicine, 40(5), 365–372. https://doi.org/10.5144/0256-4947.2020.365

Arias, F., Izquierdo-Condoy, J. S., Naranjo-Lara, P., Alarcón, V., Bonilla, P., Erazo, E., Carrington, S. J., & Ortiz-Prado, E. (2022). A Cross-Sectional Analysis of Self-Medication Patterns during the COVID-19 Pandemic in Ecuador. Medicina (Kaunas, Lithuania), 58(11). https://doi.org/10.3390/medicina58111678

Becker, M. L., Snijders, D., van Gemeren, C. W., Kingma, H. J., van Lelyveld, S. F. L., & Giezen, T. J. (2021). QTc Prolongation in COVID-19 Patients Using Chloroquine. Cardiovascular Toxicology, 21(4), 314–321. https://doi.org/10.1007/s12012-020-09621-2

Behzadifar, M., Behzadifar, M., Aryankhesal, A., Ravaghi, H., Baradaran, H. R., Sajadi, H. S., Khaksarian, M., & Bragazzi, N. L. (2020). Prevalence of self-medication in university students: systematic review and meta-analysis. Eastern Mediterranean Health Journal, 26(7), 846–857. https://doi.org/10.26719/emhj.20.052

Bhimraj, A., Morgan, R. L., Hirsch Shumaker, A., Baden, L., Chi-Chung Cheng, V., Edwards, K. M., Gallagher, J. C., Gandhi, R. T., Muller, W. J., Nakamura, M. M., O, J. C., Shafer, R. W., Shoham, S., Hassan Mu-rad, M., Mustafa, R. A., Sultan, S., & Falck-Ytter, Y. (2023). Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. www.idsociety.org/COVID19guidelines.

Corrao, S., Mallaci Bocchio, R., Lo Monaco, M., Natoli, G., Cavezzi, A., Troiani, E., & Argano, C. (2021). Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc. Nutrients, 13(4), 1261. https://doi.org/10.3390/nu13041261

DiGuilio, K. M., Rybakovsky, E., Abdavies, R., Chamoun, R., Flounders, C. A., Shepley-McTaggart, A., Harty, R. N., & Mullin, J. M. (2022). Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy. International Journal of Molecular Sciences, 23(6), 2995. https://doi.org/10.3390/ijms23062995

Elham, A. S., Azam, K., Azam, J., Mostafa, L., Nasrin, B., & Marzieh, N. (2021). Serum vitamin D, calcium, and zinc levels in patients with COVID-19. Clinical Nutrition ESPEN, 43, 276–282. https://doi.org/10.1016/j.clnesp.2021.03.040

Furtado, R. H. M., Berwanger, O., Fonseca, H. A., Corrêa, T. D., Ferraz, L. R., Lapa, M. G., Zampieri, F. G., Veiga, V. C., Azevedo, L. C. P., Rosa, R. G., Lopes, R. D., Avezum, A., Manoel, A. L. O., Piza, F. M. T., Martins, P. A., Lisboa, T. C., Pereira, A. J., Olivato, G. B., Dantas, V. C. S., … Cavalcanti, A. B. (2020). Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. The Lancet, 396(10256), 959–967. https://doi.org/10.1016/S0140-6736(20)31862-6

Golabi, S., Adelipour, M., Mobarak, S., Piri, M., Seyedtabib, M., Bagheri, R., Suzuki, K., Ashtary-Larky, D., Maghsoudi, F., & Naghashpour, M. (2021). The Association between Vitamin D and Zinc Status and the Progression of Clinical Symptoms among Outpatients Infected with SARS-CoV-2 and Potentially Non-Infected Participants: A Cross-Sectional Study. Nutrients, 13(10), 3368. https://doi.org/10.3390/nu13103368

Hinks, T. S. C., Cureton, L., Knight, R., Wang, A., Cane, J. L., Barber, V. S., Black, J., Dutton, S. J., Melhorn, J., Jabeen, M., Moss, P., Garlapati, R., Baron, T., Johnson, G., Cantle, F., Clarke, D., Elkhodair, S., Underwood, J., Lasserson, D., … Richards, D. (2021). Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial. The Lancet Respiratory Medicine, 9(10), 1130–1140. https://doi.org/10.1016/S2213-2600(21)00263-0

Hsia, B. C., Greige, N., Quiroz, J. A., Khokhar, A. S., Daily, J., Di Biase, L., Ferrick, K. J., Fisher, J. D., & Krumerman, A. (2020). QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin. Journal of Interventional Cardiac Electrophysiology, 59(2), 337–345. https://doi.org/10.1007/s10840-020-00822-x

Islam, M. S., Ferdous, M. Z., Islam, U. S., Mosaddek, A. S. M., Potenza, M. N., & Pardhan, S. (2021). Treatment, persistent symptoms, and depression in people infected with covid-19 in bangladesh. International Journal of Environmental Research and Public Health, 18(4), 1–16. https://doi.org/10.3390/ijerph18041453

Jerez-Roig, J., Medeiros, L. F. B., Silva, V. A. B., Bezerra, C. L. P. A. M., Cavalcante, L. A. R., Piuvezam, G., & Souza, D. L. B. (2014). Prevalence of Self-Medication and Associated Factors in an Elderly Population: A Systematic Review. Drugs & Aging, 31(12), 883–896. https://doi.org/10.1007/s40266-014-0217-x

Kim, M. S., An, M. H., Kim, W. J., & Hwang, T.-H. (2020). Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis. PLOS Medicine, 17(12), e1003501. https://doi.org/10.1371/journal.pmed.1003501

Lacerda, M. G. da C., Barbos, A. R. de M., & Dourado, C. S. de M. E. (2022). Acesso da população a medicamentos durante a pandemia do novo coronavírus. Revista Ciência Plural, 8(1). https://doi.org/10.21680/2446-7286.2022v8n1ID25630

Lam, S., Lombardi, A., & Ouanounou, A. (2020). COVID-19: A review of the proposed pharmacological treatments. European Journal of Pharmacology, 886, 173451. https://doi.org/10.1016/j.ejphar.2020.173451

López-Medina, E., López, P., Hurtado, I. C., Dávalos, D. M., Ramirez, O., Martínez, E., Díazgranados, J. A., Oñate, J. M., Chavarriaga, H., Herrera, S., Parra, B., Libreros, G., Jaramillo, R., Avendaño, A. C., Toro, D. F., Torres, M., Lesmes, M. C., Rios, C. A., & Caicedo, I. (2021). Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19. JAMA, 325(14), 1426. https://doi.org/10.1001/jama.2021.3071

Makowska, M., Boguszewski, R., Nowakowski, M., & Podkowińska, M. (2020). Self-medication-related behaviors and Poland’s Covid-19 lockdown. International Journal of Environmental Research and Public Health, 17(22), 1–19. https://doi.org/10.3390/ijerph17228344

Manea, E., Jipa, R., Milea, A., Roman, A., Neagu, G., & Hristea, A. (2021). Healthcare-associated Clostridioides difficile infection during the COVID-19 pandemic in a tertiary care hospital in Romania. Romanian Journal of Internal Medicine, 59(4), 409–415. https://doi.org/10.2478/rjim-2021-0020

Mohan, A., Tiwari, P., Suri, T., Patel, A., Jain, A., Kumar Das, U., Bopanna, T. K., Shelke, S., Rajan Singh, A., Bhatnagar, S., Masih Mahajan Imaging Shelly Mahajan Mahajan Imaging Tanima Dwivedi, S., Sahoo, B., Bhopale, S., Vig, S., Gupta, R., Madan, K., Hadda, V., Gupta, N., Garg, R., … Guleria, R. (2021). Ivermectin in mild and moderate COVID-19 (RIVET-COV): a randomized, placebo-controlled trial. Research Square. https://doi.org/10.21203/rs.3.rs-191648/v1

Muller, R. (2021). Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities. Rheumatology International, 41(7), 1189–1202. https://doi.org/10.1007/s00296-021-04868-6

Notz, Q., Herrmann, J., Schlesinger, T., Helmer, P., Sudowe, S., Sun, Q., Hackler, J., Roeder, D., Lotz, C., Meybohm, P., Kranke, P., Schomburg, L., & Stoppe, C. (2021). Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS. Nutrients, 13(6), 2113. https://doi.org/10.3390/nu13062113

Okoye, O. C., Adejumo, O. A., Opadeyi, A. O., Madubuko, C. R., Ntaji, M., Okonkwo, K. C., Edeki, I. R., Agboje, U. O., Alli, O. E., & Ohaju-Obodo, J. O. (2022). Self medication practices and its determinants in health care professionals during the coronavirus disease-2019 pandemic: cross-sectional study. International Journal of Clinical Pharmacy, 44(2), 507–516. https://doi.org/10.1007/s11096-021-01374-4

Oldenburg, C. E., Pinsky, B. A., Brogdon, J., Chen, C., Ruder, K., Zhong, L., Nyatigo, F., Cook, C. A., Hinterwirth, A., Lebas, E., Redd, T., Porco, T. C., Lietman, T. M., Arnold, B. F., & Doan, T. (2021). Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. JAMA, 326(6), 490. https://doi.org/10.1001/jama.2021.11517

Onchonga, D., Omwoyo, J., & Nyamamba, D. (2020). Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya. Saudi Pharmaceutical Journal, 28(10), 1149–1154. https://doi.org/10.1016/j.jsps.2020.08.003

Preskorn, S. H., & Quadri, S. (2020). Why Are Patients With COVID-19 at Risk for Drug-Drug Interactions? Journal of psychiatric practice, 26(6), 485–492. https://doi.org/10.1097/PRA.0000000000000502

Rashid, M., Chhabra, M., Kashyap, A., Undela, K., & Gudi, S. K. (2020). Prevalence and Predictors of Self-Medication Practices in India: A Systematic Literature Review and Meta-Analysis. Current Clinical Pharmacology, 15(2), 90–101. https://doi.org/10.2174/1574884714666191122103953

Ruamviboonsuk, P., Lai, T. Y. Y., Chang, A., Lai, C.-C., Mieler, W. F., & Lam, D. S. C. (2020). Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19. Asia-Pacific Journal of Ophthalmology, 9(2), 85–87. https://doi.org/10.1097/APO.0000000000000289

Sadio, A. J., Gbeasor-Komlanvi, F. A., Konu, R. Y., Bakoubayi, A. W., Tchankoni, M. K., Bitty-Anderson, A. M., Gomez, I. M., Denadou, C. P., Anani, J., Kouanfack, H. R., Kpeto, I. K., Salou, M., & Ekouevi, D. K. (2021). Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-020-10145-1

Saleh, M., Gabriels, J., Chang, D., Soo Kim, B., Mansoor, A., Mahmood, E., Makker, P., Ismail, H., Goldner, B., Willner, J., Beldner, S., Mitra, R., John, R., Chinitz, J., Skipitaris, N., Mountantonakis, S., & Epstein, L. M. (2020). Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection. Circulation: Arrhythmia and Electrophysiology, 13(6). https://doi.org/10.1161/CIRCEP.120.008662

Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). JAMA. https://doi.org/10.1001/jama.2020.6019

Sciannameo, S., Zalazar, V., Aristegui, I., Parera, D., & Sued, O. (20222). Encuesta sobre el impacto de la pandemia COVID-19 en el consumo de medicamentos, drogas recreativas y bebidas alcohólicas en Argentina Survey on the impact of the COVID-19 pandemic on the consumption of medicines, recreational drugs and alcoholic beverages in Argentina. Rev. OFIL·ILAPHA, 32(4), 347–353. https://doi.org/10.4321/S1699-714X2022000400007

Shehnaz, S. I., Agarwal, A. K., & Khan, N. (2014). A Systematic Review of Self-Medication Practices Among Adolescents. Journal of Adolescent Health, 55(4), 467–483. https://doi.org/10.1016/j.jadohealth.2014.07.001

Sisay, M., Mengistu, G., & Edessa, D. (2018). Epidemiology of self-medication in Ethiopia: a systematic review and meta-analysis of observational studies. BMC Pharmacology and Toxicology, 19(1), 56. https://doi.org/10.1186/s40360-018-0248-8

Souza, M. T. de, Silva, M. D. da, & Carvalho, R. de. (2010). Integrative review: what is it? How to do it? Einstein (São Paulo), 8(1), 102–106. https://doi.org/10.1590/s1679-45082010rw1134

Story, M. J. (2021). Essential sufficiency of zinc, ω-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment of COVID-19, diabetes, cardiovascular diseases, lung diseases and cancer. Biochimie, 187, 94–109. https://doi.org/10.1016/j.biochi.2021.05.013

Tasnim, S., Hossain, M. M., & Mazumder, H. (2020). Impact of Rumors and Misinformation on COVID-19 in Social Media. Journal of Preventive Medicine and Public Health, 53(3), 171–174. https://doi.org/10.3961/jpmph.20.094

Teng, C., Reveles, K. R., Obodozie-Ofoegbu, O. O., & Frei, C. R. (2019). Clostridium difficile Infection Risk with Important Antibiotic Classes: An Analysis of the FDA Adverse Event Reporting System. International Journal of Medical Sciences, 16(5), 630–635. https://doi.org/10.7150/ijms.30739

The RECOVERY Collaborative Group. (2020). Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine, 383(21), 2030–2040. https://doi.org/10.1056/NEJMoa2022926

Wegbom, A. I., Edet, C. K., Raimi, O., Fagbamigbe, A. F., & Kiri, V. A. (2021). Self-Medication Practices and Associated Factors in the Prevention and/or Treatment of COVID-19 Virus: A Population-Based Survey in Nigeria. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.606801

WHO Solidarity Trial Consortium. (2021). Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results. New England Journal of Medicine, 384(6), 497–511. https://doi.org/10.1056/NEJMoa2023184

World Health Organization (WHO). (2000). Guidelines for the regulatory assessment of medicinal products for use in self-medication. Retrieved from: https://apps.who.int/iris/handle/10665/66154

World Health Organization (WHO). (2020, abril 19). The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. Retrieved from: https://www.who.int/news-room/commentaries/detail/the-use-of-non-steroidal-anti-inflammatory-drugs-(nsaids)-in-patients-with-covid-19

World Health Organization (WHO). (2023a). Clinical management of COVID-19: living guideline. Retrieved from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2023.1

World Health Organization (WHO). (2023b). Drugs to prevent COVID-19: living guideline. Retrieved from: https://www.who.int/publications/i/item/WHO-2019-nCoV-prophylaxes-2023.1

World Health Organization (WHO). (2023c). Therapeutics and COVID-19: living guideline. Retrieved from: https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2023.1

Yasmin, F., Asghar, M. S., Naeem, U., Najeeb, H., Nauman, H., Ahsan, M. N., & Khattak, A. K. (2022). Self-Medication Practices in Medical Students During the COVID-19 Pandemic: A Cross-Sectional Analysis. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.803937

Yusuf, I., & Sarkinfada, F. (2021). Gaps in the implementation of covid-19 mitigation measures could lead to development of new strains of antimicrobial resistant pathogens: Nigerian perspective. Em Pan African Medical Journal (Vol. 40). African Field Epidemiology Network. https://doi.org/10.11604/pamj.2021.40.12.23274

Downloads

Publicado

12/06/2023

Como Citar

DANTAS, F. S. E.; COUTINHO, V. E. A.; CAROLINO, R. de A.; SARMENTO, T. de A. B.; CUNHA, C. V. L. da .; SILVA, C. P. da .; FERREIRA, M. L. Automedicação no contexto de COVID-19, os perigos da prática e fatores associados. Research, Society and Development, [S. l.], v. 12, n. 6, p. e11912642039, 2023. DOI: 10.33448/rsd-v12i6.42039. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/42039. Acesso em: 23 nov. 2024.

Edição

v. 12 n. 6

Seção

Ciências da Saúde

Licença

Copyright (c) 2023 Francisco Samuel Estrela Dantas; Vanessa Erika Abrantes Coutinho; Rodolfo de Abreu Carolino; Thaise de Abreu Brasileiro Sarmento; Caio Visalli Lucena da Cunha; Camila Pereira da Silva; Matheus Leite Ferreira

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.

Autores que publicam nesta revista concordam com os seguintes termos:

1) Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.

2) Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.

3) Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado.